Hot Keywords
Tumor Microenvironment Exosomes and Extracellular Vesicles Breast Cancer Metastasis Bone Metastasis Metastatic Renal Cell Carcinoma Lymph node metastasis Mesothelioma Hematological Malignancies Thyroid Cancer Liquid Biopsies Early Diagnosis Lung Cancer Brain Tumors Lymphoma Oncolytic Virus Cervical Cancer Cancer Stem Cells

The paper's citation list
No.The paper's citation list
1Neurologische Nebenwirkungen von Checkpoint-Inhibitoren. 2019;90:138 doi: 10.1007/s00115-018-0571-8
2Pembrolizumab leading to complete resolution of non-small cell lung cancer and microsatellite instability stable colon adenocarcinoma; two birds one stone. 2022;8:20 doi: 10.5348/100111Z10PB2022CR
3Space-velocity thermostatted kinetic theory model of tumor growth. 2021;18:5525 doi: 10.3934/mbe.2021279
4Emerging Antibodies in Cancer Therapy. 2023;3:2200083 doi: 10.1002/anbr.202200083
5Cell density quantification with TurboSPI: R2* mapping with compensation for off-resonance fat modulation. 2020;33:469 doi: 10.1007/s10334-019-00817-4
6Immunotherapeutic Strategies in Cancer and Atherosclerosis—Two Sides of the Same Coin. 2022;8: doi: 10.3389/fcvm.2021.812702
7Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives. 2021;19: doi: 10.1186/s12951-021-00861-0
8Recent Progress of Alkyl Radicals Generation‐Based Agents for Biomedical Applications. 2021;10:2100055 doi: 10.1002/adhm.202100055
9Cancer Biology and Advances in Treatment. 2020;1292:113 doi: 10.1007/5584_2020_522
10Handbook of Cancer and Immunology. 2023;1 doi: 10.1007/978-3-030-80962-1_180-1
11Immunotherapy approaches for hematological cancers. 2022;25:105326 doi: 10.1016/j.isci.2022.105326
12Injectable immunogel based on polymerized phenylboronic acid and mannan for cancer immunotherapy. 2022;345:138 doi: 10.1016/j.jconrel.2022.03.009
13Immunocompetent cancer-on-chip models to assess immuno-oncology therapy. 2021;173:281 doi: 10.1016/j.addr.2021.03.015
14Cancer immunotherapy: Recent advances and challenges. 2021;17:834 doi: 10.4103/jcrt.JCRT_1241_20
15Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients. 2022;9:327 doi: 10.3390/vetsci9070327
16Systems Medicine. 2021;593 doi: 10.1016/B978-0-12-801238-3.11605-8
17Cell Interaction - Molecular and Immunological Basis for Disease Management. 2021; doi: 10.5772/intechopen.94560
18A comprehensive review on immuno-nanomedicine for breast cancer therapy: Technical challenges and troubleshooting measures. 2022;103:108433 doi: 10.1016/j.intimp.2021.108433
19Handbook of Microbial Nanotechnology. 2022;17 doi: 10.1016/B978-0-12-823426-6.00004-8
20Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune System. 2022;10:1842 doi: 10.3390/biomedicines10081842
21Immunotherapies and Combination Strategies for Immuno-Oncology. 2020;21:5009 doi: 10.3390/ijms21145009
22Novel Clinical Trial Designs and Statistical Methods in the Era of Precision Medicine. 2021;13:133 doi: 10.1080/19466315.2020.1814403
23Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice. 2018;50:1 doi: 10.1038/s12276-018-0115-0
24Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy. 2020;9:2967 doi: 10.3390/jcm9092967
25Understanding Cancer. 2022;269 doi: 10.1016/B978-0-323-99883-3.00004-4
26Principles of Tumors. 2020;453 doi: 10.1016/B978-0-12-816920-9.00018-3
27CRISPR/Cas9 for Cancer Therapy: Hopes and Challenges. 2018;6:105 doi: 10.3390/biomedicines6040105
28Bioactive Nanoparticles for Cancer Immunotherapy. 2018;19:3877 doi: 10.3390/ijms19123877
29MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer. 2019;303:223 doi: 10.1016/j.jconrel.2019.04.019
30Systemic anticancer therapies and the role of primary care. 2020;31:22 doi: 10.1002/psb.1871
31Peptide-based targeting of immunosuppressive cells in cancer. 2020;5:92 doi: 10.1016/j.bioactmat.2020.01.006
32Prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma: A systematic review and comprehensive meta-analysis. 2020;106:104722 doi: 10.1016/j.oraloncology.2020.104722
33The Golden Guide to Oncologic Pharmacy. 2022;243 doi: 10.1007/978-3-030-98596-7_7
34Studying the Anticancer Effects of Thymoquinone on Breast Cancer Cells through Natural Killer Cell Activity. 2022;2022:1 doi: 10.1155/2022/9218640
35Immunotherapy – A Novel Facet of Modern Therapeutics. 2021;1 doi: 10.1007/978-981-15-9038-2_1
36ATP stabilised and sensitised calcium phosphate nanoparticles as effective adjuvants for a DNA vaccine against cancer. 2021;9:7435 doi: 10.1039/D1TB01408K
37Principles of Translational Science in Medicine. 2021;307 doi: 10.1016/B978-0-12-820493-1.00033-7
38Biomaterials for Cancer Therapeutics. 2020;331 doi: 10.1016/B978-0-08-102983-1.00012-0
39The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors. 2022;34:189 doi: 10.3233/CBM-210349
40Immunostimulatory biomaterials to boost tumor immunogenicity. 2020;8:5516 doi: 10.1039/D0BM01183E
41Tumor Innervation: History, Methodologies, and Significance. 2022;14:1979 doi: 10.3390/cancers14081979
42Drug Delivery Devices and Therapeutic Systems. 2021;423 doi: 10.1016/B978-0-12-819838-4.00016-X
43Health-related quality of life in cancer immunotherapy: a systematic perspective, using causal loop diagrams. 2022;31:2357 doi: 10.1007/s11136-022-03110-5
44Glycoconjugate Nanoparticle-Based Systems in Cancer Immunotherapy: Novel Designs and Recent Updates. 2022;13: doi: 10.3389/fimmu.2022.852147
45Biomedical Translational Research. 2022;413 doi: 10.1007/978-981-16-8845-4_21
46Delivery of a Cancer-Testis Antigen-Derived Peptide Using Conformationally Restricted Dipeptide-Based Self-Assembled Nanotubes. 2021;18:3832 doi: 10.1021/acs.molpharmaceut.1c00451
47Durability of response in metastatic melanoma patients after combined treatment with radiation therapy and ipilimumab. 2020;7: doi: 10.2217/mmt-2019-0020
48The discovery of potent small molecule activators of human STING. 2021;209:112869 doi: 10.1016/j.ejmech.2020.112869
49Nanotherapeutics in Cancer Vaccination and Challenges. 2022;29 doi: 10.1016/B978-0-12-823686-4.00018-5
50Cancer and the Immune System: The History and Background of Immunotherapy. 2019;35:150923 doi: 10.1016/j.soncn.2019.08.002
51Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer. 2022;346:43 doi: 10.1016/j.jconrel.2022.04.007
52The need for rapid therapeutic efficacy testing for cancer therapy. 2020;113:104382 doi: 10.1016/j.yexmp.2020.104382
53Integrative Nanomedicine for New Therapies. 2020;321 doi: 10.1007/978-3-030-36260-7_12
54Emerging therapeutic agents for advanced non-small cell lung cancer. 2020;13: doi: 10.1186/s13045-020-00881-7
55The second near-infrared window quantum dot-based fluorescence anisotropy probes for separation-free, sensitive and rapid detection of small extracellular vesicle PD-L1 in plasma samples. 2023;376:132962 doi: 10.1016/j.snb.2022.132962
56Immunosuppression. 2020; doi: 10.5772/intechopen.94754
57Molecular and Cell Biology of Cancer. 2019;117 doi: 10.1007/978-3-030-11812-9_7
58Cancer Immunotherapy: Diverse Approaches and Obstacles. 2022;28:2387 doi: 10.2174/1381612828666220728160519
59Nano-ablative immunotherapy for cancer treatment. 2021;10:3247 doi: 10.1515/nanoph-2021-0171
60Targeting cancer-associated glycans as a therapeutic strategy in leukemia. 2022;15:378 doi: 10.1080/26895293.2022.2049901
61The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapy. 2021;70:98 doi: 10.1016/j.semcancer.2020.07.012
62A SIRPαFc Fusion Protein Conjugated With the Collagen-Binding Domain for Targeted Immunotherapy of Non-Small Cell Lung Cancer. 2022;13: doi: 10.3389/fimmu.2022.845217
63Nano-immunotherapeutics: targeting approach as strategic regulation at tumor microenvironment for cancer treatment. 2022;22 doi: 10.37349/emed.2022.00072
64Cytokine Therapy Combined with Nanomaterials Participates in Cancer Immunotherapy. 2022;14:2606 doi: 10.3390/pharmaceutics14122606
65Current Applications for Overcoming Resistance to Targeted Therapies. 2019;20:97 doi: 10.1007/978-3-030-21477-7_4
66Th1 cytokines in conjunction with pharmacological Akt inhibition potentiate apoptosis of breast cancer cells in vitro and suppress tumor growth in vivo. 2020;11:2873 doi: 10.18632/oncotarget.27556
67Phosphorothioated amino-AS1411 aptamer functionalized stealth nanoliposome accelerates bio-therapeutic threshold of apigenin in neoplastic rat liver: a mechanistic approach. 2023;21: doi: 10.1186/s12951-022-01764-4
68Human health and snails. 2021;42:211 doi: 10.1080/15321819.2020.1844751
69William B. Coley. 2020;47:413 doi: 10.1016/j.ucl.2020.07.001
70The Microbiome in Health and Disease. 2020;171:301 doi: 10.1016/bs.pmbts.2020.04.004
71Analysis of tumor-immune functional responses in a mathematical model of neoantigen cancer vaccines. 2023;356:108966 doi: 10.1016/j.mbs.2023.108966
72Handbook on Synthesis Strategies for Advanced Materials. 2021;643 doi: 10.1007/978-981-16-1892-5_14
73CRISPR/Cas9 technology: towards a new generation of improved CAR-T cells for anticancer therapies. 2020;19:191 doi: 10.1093/bfgp/elz039
74Picolylamine-functionalized benz[e]indole squaraine dyes: Synthetic approach, characterization and in vitro efficacy as potential anticancer phototherapeutic agents. 2022;229:114071 doi: 10.1016/j.ejmech.2021.114071
75Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy. 2022;52:415 doi: 10.1007/s40005-022-00569-9
76Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications. 2021;22:166 doi: 10.1016/j.omto.2021.08.005
77Nucleic acid and oligonucleotide delivery for activating innate immunity in cancer immunotherapy. 2022;345:586 doi: 10.1016/j.jconrel.2022.03.045
78New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid Tumors. 2022;24:651 doi: 10.1007/s11912-022-01218-y
79The Intriguing History of Cancer Immunotherapy. 2019;10: doi: 10.3389/fimmu.2019.02965
80Immunotherapies for hepatocellular carcinoma. 2022;11:571 doi: 10.1002/cam4.4468
81Cancer Immunotherapy: An Effective Tool in Cancer Control and Treatment. 2020;16:62 doi: 10.2174/1573394715666190913184853
82Nanotherapeutics in Cancer Vaccination and Challenges. 2022;295 doi: 10.1016/B978-0-12-823686-4.00019-7
83Advanced Fermentation and Cell Technology. 2021;579 doi: 10.1002/9781119042792.part3
84Exploiting Cancer’s Tactics to Make Cancer a Manageable Chronic Disease. 2020;12:1649 doi: 10.3390/cancers12061649
85Immunotherapy. 2020;1244:255 doi: 10.1007/978-3-030-41008-7_13
86Strategies for Targeting Cancer Immunotherapy Through Modulation of the Tumor Microenvironment. 2020;6:29 doi: 10.1007/s40883-019-00113-6
87Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas. 2020;12:432 doi: 10.3390/cancers12020432
88Drug Repurposing for Triple-Negative Breast Cancer. 2020;10:200 doi: 10.3390/jpm10040200
89The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors. 2022;Publish Ahead of Print: doi: 10.1097/CAD.0000000000001463
90Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy. 2022;23:127 doi: 10.1080/15384047.2022.2033057
91Immune System Efficiency in Cancer and the Microbiota Influence. 2021;88:170 doi: 10.1159/000512326
92A guide through conventional and modern cancer treatment modalities: A specific focus on glioblastoma cancer therapy (Review). 2022;48: doi: 10.3892/or.2022.8405
93Understanding immunotherapy and its management. 2021;001 doi: 10.17352/2455-8591.000030
94Immunotherapy: an alternative promising therapeutic approach against cancers. 2022;49:9903 doi: 10.1007/s11033-022-07525-8
95 ; ; ; doi:
96Bovine Dialyzable Leukocyte Extract IMMUNEPOTENT-CRP Induces Selective ROS-Dependent Apoptosis in T-Acute Lymphoblastic Leukemia Cell Lines. 2020;2020:1 doi: 10.1155/2020/1598503
97Recent Progress in the Synergistic Combination of Nanoparticle‐Mediated Hyperthermia and Immunotherapy for Treatment of Cancer. 2021;10:2001415 doi: 10.1002/adhm.202001415
98A Hepatitis B Virus-Derived Peptide Exerts an Anticancer Effect via TNF/iNOS-producing Dendritic Cells in Tumor-Bearing Mouse Model. 2021;13:407 doi: 10.3390/cancers13030407
99Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma. 2021;12: doi: 10.3389/fgene.2021.744304
100Cell membrane coated-nanoparticles for cancer immunotherapy. 2022;12:3233 doi: 10.1016/j.apsb.2022.02.023
101Emerging Trends in Immunotherapy for Cancer. 2022;10:60 doi: 10.3390/diseases10030060
102Editorial. 2020;43:5 doi: 10.1159/000510546
103Tracing New Landscapes in the Arena of Nanoparticle-Based Cancer Immunotherapy. 2022;4: doi: 10.3389/fnano.2022.911063
104The emergence of drug resistance to targeted cancer therapies: Clinical evidence. 2019;47:100646 doi: 10.1016/j.drup.2019.100646
105Immunotherapy. 2018;995:131 doi: 10.1007/978-3-030-02505-2_6
106Xeroderma Pigmentosum: A Genetic Condition Skin Cancer Correlated—A Systematic Review. 2022;2022:1 doi: 10.1155/2022/8549532
107Recent advances in localized immunotherapy of skin cancers. 2019;11:443 doi: 10.2217/imt-2018-0139
108Multiple White Plaques in the Esophagus: A Possible Case of Esophageal Mucosal Alteration Associated With Immune-Related Adverse Events of Immune Checkpoint Inhibitors. 2022; doi: 10.7759/cureus.32710
109Recent advancements in immunotherapy of melanoma using nanotechnology-based strategies. 2023;159:114243 doi: 10.1016/j.biopha.2023.114243
110Checkpoint inhibitors: What gastroenterologists need to know. 2018;24:5433 doi: 10.3748/wjg.v24.i48.5433
111Pembrolizumab: The Nut Cracker. 2020;41:393 doi: 10.4103/ijmpo.ijmpo_37_20
112Biomaterial Based Approaches to Study the Tumour Microenvironment. 2022;342 doi: 10.1039/9781839166013-00342
113Handbook of Cancer and Immunology. 2022;1 doi: 10.1007/978-3-030-80962-1_183-1
114Exosomes Represent an Immune Suppressive T Cell Checkpoint in Human Chronic Inflammatory Microenvironments. 2020;49:726 doi: 10.1080/08820139.2020.1748047
115Editorial. 2019;12:3 doi: 10.1111/ors.12402
116Ecology of Fear: Spines, Armor and Noxious Chemicals Deter Predators in Cancer and in Nature. 2021;9: doi: 10.3389/fevo.2021.682504
117The role of Globo H and SSEA-4 in the development and progression of cancer, and their potential as therapeutic targets. 2022;18:117 doi: 10.2217/fon-2021-1110
118Active immunotherapy of cancer: An overview of therapeutic vaccines. 2019;69:490 doi: 10.5937/arhfarm1906490F
119Combined strategies for tumor immunotherapy with nanoparticles. 2019;21:1441 doi: 10.1007/s12094-019-02081-3
120Modeling immune cell behavior across scales in cancer. 2020;12: doi: 10.1002/wsbm.1484
121Immunotherapy for HER2-Positive Breast Cancer: Changing the Paradigm. 2019;11:248 doi: 10.1007/s12609-019-00332-4
122The exploitation of enzyme-based cancer immunotherapy. 2022;36:98 doi: 10.1007/s13577-022-00821-2
123Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer. 2019;9: doi: 10.3389/fonc.2019.00396
124Trends in Biomathematics: Stability and Oscillations in Environmental, Social, and Biological Models. 2022;225 doi: 10.1007/978-3-031-12515-7_12
125Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms. 2021;22:1301 doi: 10.1007/s10198-021-01337-6
126On the very idea of pursuitworthiness. 2022;91:103 doi: 10.1016/j.shpsa.2021.11.016
127Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells. 2020;37:354 doi: 10.1016/j.ccell.2020.02.001
128Checkpoint Inhibitors in Gynecological Malignancies: Are we There Yet?. 2020;34:749 doi: 10.1007/s40259-020-00450-x
129Antibody–drug conjugates, cancer immunotherapy, and metronomic chemotherapy as novel approaches in cancer management. 2020;52:402 doi: 10.4103/ijp.IJP_475_18
130A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy. 2019;18:1081 doi: 10.1158/1535-7163.MCT-18-0737
131Immunotherapy and other systemic therapies for cutaneous SCC. 2019;99:104459 doi: 10.1016/j.oraloncology.2019.104459
132Fatty Acid Metabolism and Cancer Immunotherapy. 2022;24:659 doi: 10.1007/s11912-022-01223-1
133Commensal Microbiota and Cancer Immunotherapy: Harnessing Commensal Bacteria for Cancer Therapy. 2022;22: doi: 10.4110/in.2022.22.e3
134On the development of a neoantigen vaccine for the prevention of Lynch Syndrome. 2022;151:107 doi: 10.1002/ijc.33971
135O-acetylated Gangliosides as Targets for Cancer Immunotherapy. 2020;9:741 doi: 10.3390/cells9030741
136Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection. 2020;20: doi: 10.1186/s12874-020-00997-x
137The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy. 2022;29: doi: 10.1186/s12929-022-00796-0
138The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors. 2020;10:666 doi: 10.3390/biom10050666
139RNA methylation and cellular response to oxidative stress-promoting anticancer agents. 2023;1 doi: 10.1080/15384101.2023.2165632
140Immunity Management Post Cancer Therapy. 2022;24 doi: 10.52711/2231-5691.2022.00005
141Novel therapeutic strategies for spinal osteosarcomas. 2020;64:83 doi: 10.1016/j.semcancer.2019.05.018
142Spontaneous regression of adenocarcinoma of submandibular gland. 2021;87:486 doi: 10.1016/j.bjorl.2020.10.014
143Recent progress in cancer immunotherapy: Overview of current status and challenges. 2023;241:154241 doi: 10.1016/j.prp.2022.154241
144The Landscape of Nanovectors for Modulation in Cancer Immunotherapy. 2022;14:397 doi: 10.3390/pharmaceutics14020397
145Tumor-associated macrophages: Shifting bad prognosis to improved efficacy in cancer therapies?. 2021;015 doi: 10.17352/2455-8591.000032
146Efficacy of immunotherapy with PD-1 inhibitor in colorectal cancer: a meta-analysis. 2020;9:1285 doi: 10.2217/cer-2020-0040
147Recent Advances in the Use of Plant Virus-Like Particles as Vaccines. 2020;12:270 doi: 10.3390/v12030270
148Recent developments in antibody derivatives against colorectal cancer; A review. 2021;265:118791 doi: 10.1016/j.lfs.2020.118791
149An Overview on Immunogenic Cell Death in Cancer Biology and Therapy. 2022;14:1564 doi: 10.3390/pharmaceutics14081564
150Cancer: The Enemy from Within. 2020;223 doi: 10.1007/978-3-030-40651-6_9
151Burger's Medicinal Chemistry and Drug Discovery. 2021;1 doi: 10.1002/0471266949.bmc157.pub2
152Learning-accelerated discovery of immune-tumour interactions. 2019;4:747 doi: 10.1039/C9ME00036D
153Antitumour metastasis and the antiangiogenic and antitumour effects of a Eimeria stiedae soluble protein. 2021;43: doi: 10.1111/pim.12825
154Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T. 2020;112:562 doi: 10.1093/jnci/djaa021
155Immunotherapy. 2021;1342:357 doi: 10.1007/978-3-030-79308-1_14
156Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma. 2022;12:2820 doi: 10.1158/2159-8290.CD-22-0196
157Resistance to Targeted Therapies in Lymphomas. 2019;21:155 doi: 10.1007/978-3-030-24424-8_7
158Cardiovascular toxicity and therapeutic modalities targeting cardio-oncology. 2022;39 doi: 10.1016/B978-0-323-90461-2.00001-8
159A guide to cancer immunotherapy: from T cell basic science to clinical practice. 2020;20:651 doi: 10.1038/s41577-020-0306-5
160Nanoformulation Strategies for Cancer Treatment. 2021;207 doi: 10.1016/B978-0-12-821095-6.00003-3
161Humanized Germ-Free Mice for Investigating the Intervention Effect of Commensal Microbiome on Cancer Immunotherapy. 2022;37:1291 doi: 10.1089/ars.2022.0039
162Molecular Stacking Composite Nanoparticles of Gossypolone and Thermodynamic Agent for Elimination of Large Tumor in Mice via Electrothermal‐Thermodynamic‐Chemo Trimodal Combination Therapy. 2022;32:2201666 doi: 10.1002/adfm.202201666
163Current trends in cancer immunotherapy: a literature-mining analysis. 2020;69:2425 doi: 10.1007/s00262-020-02630-8
164Translational Biotechnology. 2021;233 doi: 10.1016/B978-0-12-821972-0.00014-9
165Overview of Current Immunotherapies Targeting Mutated KRAS Cancers. 2019;19:2158 doi: 10.2174/1568026619666190904163524
166Redrawing therapeutic boundaries: microbiota and cancer. 2022;8:87 doi: 10.1016/j.trecan.2021.10.008
167Microsatellite Instability in Russian Patients with Colorectal Cancer. 2022;23:7062 doi: 10.3390/ijms23137062
168miRNAs as novel immunoregulators in cancer. 2022;124:3 doi: 10.1016/j.semcdb.2021.04.013
169Nanoparticles: Properties and Applications in Cancer Immunotherapy. 2019;25:1962 doi: 10.2174/1381612825666190708214240
170Precision Medicine in Oncology. 2020;133 doi: 10.1002/9781119432487.ch5
© 2016-2023 OAE Publishing Inc., except certain content provided by third parties